Patients with diabetes are at higher risk for severe illness from COVID-19 - 11/09/20
Doi : 10.1016/j.diabet.2020.05.001
G. Targher a, ⁎ 
, A. Mantovani a, X.-B. Wang b, H.-D. Yan c, Q.-F. Sun d, K.-H. Pan e, C.D. Byrne f, K.I. Zheng g, Y.-P. Chen g, h, M. Eslam i, J. George i, M.-H. Zheng g, h, j, ⁎
, A. Mantovani a, X.-B. Wang b, H.-D. Yan c, Q.-F. Sun d, K.-H. Pan e, C.D. Byrne f, K.I. Zheng g, Y.-P. Chen g, h, M. Eslam i, J. George i, M.-H. Zheng g, h, j, ⁎ a Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy
b Department of Critical Care Medicine, Wenzhou Central Hospital, Wenzhou, China
c Department of Hepatology, Key Laboratory of Diagnosis and Treatment of Digestive System Tumours of Zhejiang Province, Hwamei Hospital, Ningbo No.2 Hospital, University of Chinese Academy of Sciences, Ningbo, China
d Department of Infectious Diseases, Ruian People's Hospital, Wenzhou, China
e Department of Radiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
f Southampton National Institute for Health Research Biomedical Research Centre, University Hospital Southampton, Southampton General Hospital, Southampton, UK
g MAFLD Research Centre, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
h Institute of Hepatology, Wenzhou Medical University, Wenzhou, China
i Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Sydney, Australia
j Laboratory of Diagnosis and Treatment for The Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, China
⁎Corresponding author at: Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata, Piazzale Stefani 1, 37126 Verona, Italy.Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria IntegrataPiazzale Stefani 1Verona37126Italy⁎⁎MAFLD Research Center, Department of Hepatologythe First Affiliated Hospital of Wenzhou Medical University, No. 2 Fuxue Lane, 325000 Wenzhou, China.MAFLD Research Center, Department of Hepatologythe First Affiliated Hospital of Wenzhou Medical UniversityNo. 2 Fuxue LaneWenzhouWenzhou325000Italy
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Highlights |
• | It is currently uncertain whether people with diabetes are at higher risk of severe illness from coronavirus disease 2019 (COVID-19). |
• | We found that diabetes was associated with an approximately 4-fold increased risk of having severe/critical COVID-19 illness. |
• | This association was independent of age, sex, obesity, hypertension and smoking. |
• | These findings highlight the urgent need for a multidisciplinary team-based approach to management of this patient population. |
Plan
© 2020
Elsevier Masson SAS. Tous droits réservés.
Vol 46 - N° 4
P. 335-337 - septembre 2020 Retour au numéro
Article précédent
- Association of treatment-achieved HbA1c with incidence of coronary artery disease and severe eye disease in diabetes patients
- M. Harada, K. Fujihara, T. Osawa, M. Yamamoto, M. Kaneko, M. Ishizawa, Y. Matsubayashi, T. Yamada, N. Yamanaka, H. Seida, S. Kodama, W. Ogawa, H. Sone
- Metformin misuse in chronic kidney disease
- V. Coliche, L. Koppe, M. Laville, M. Nouvier, S. Pelletier, P. Trolliet, D. Fouque
Bienvenue sur EM-consulte, la référence des professionnels de santé.